Topic Hub
8 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 8 of 8 clinical reviews.
A clinician-reviewed deep dive into the emerging mechanisms behind menopause, covering kisspeptin-neurokinin B-dynorphin signaling, neuroinflammation, mitochondrial biology, and what these findings mean for treatment decisions.
Read clinical reviewA clinician-reviewed look at how many people experience menopause worldwide, regional age-at-menopause differences, rising life-expectancy implications, and what epidemiological trends mean for treatment planning.
Read clinical reviewA clinical timeline of menopause treatment from the 1940s to today, covering estrogen therapy, the WHI trial, and current hormone and non-hormone options with guideline-based guidance.
Read clinical reviewMenopause does not occur in children under normal circumstances, but premature ovarian insufficiency, cancer treatment, and surgical oophorectomy can trigger menopause-like states at any age. Learn how the physiology, symptoms, hormone therapy protocols, and long-term risks differ across the lifespan.
Read clinical reviewFrom hormone therapy timing to cardiovascular risk, bioidentical hormones, and testosterone use in women, this HealthRX clinical review covers the active controversies shaping menopause care in 2024.
Read clinical reviewBlack, Hispanic, Asian, and Indigenous women experience menopause differently from white women across timing, symptom severity, hormone therapy access, and cardiovascular risk. This evidence-based guide explains the gaps and what clinicians should do about them.
Read clinical reviewA clinically detailed guide to the uncommon and misdiagnosed faces of menopause, including rare vasomotor variants, neurological symptoms, skin and joint changes, and premature ovarian insufficiency, with primary-source citations and physician-reviewed guidance.
Read clinical reviewA clinically grounded analysis of menopause's socioeconomic burden, including lost productivity, healthcare spending, workforce attrition, and the economic case for evidence-based HRT and GLP-1 therapy.
Read clinical review